Segment and Other Information - Reconciliation of Unallocated Amounts (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 28, 2025	Aug. 29, 2024	Aug. 31, 2023
Segment reporting information
Stock-based compensation expense	$ 975	$ 821	$ 557
Provision to write down inventories to net realizable value	0	0	1,831
Cost of goods sold	22,505	19,498	16,956
Research and development	3,798	3,430	3,114
Restructure and asset impairments	39	1	171
Patent license charges	$ 57	$ 0	$ 0
Goodwill impairment, income statement line item	Other operating (income) expense, net	Other operating (income) expense, net	Other operating (income) expense, net
Goodwill impairment	$ 0	$ 0	$ 101
Litigation settlement	0	0	68
Patent cross-license agreement gain	0	(200)	0
Other operating (income) expense, net	(61)	251	(124)
Operating income (loss)	9,770	1,304	(5,745)
Cost of goods sold
Segment reporting information
Stock-based compensation expense	409	312	201
Research and development
Segment reporting information
Stock-based compensation expense	347	296	226
Selling, general, and administrative
Segment reporting information
Stock-based compensation expense	219	213	137
Unallocated
Segment reporting information
Cost of goods sold	413	(657)	1,207
Research and development	348	282	226
Restructure and asset impairments	39	1	171
Goodwill impairment	0	0	101
Other operating (income) expense, net	(57)	195	(172)
Operating income (loss)	(1,076)	356	(1,913)
Unallocated | Cost of goods sold
Segment reporting information
Stock-based compensation expense	409	312	201
Provision to write down inventories to net realizable value	0	0	1,831
Lower costs from sale of inventory written down in prior periods	0	(987)	(844)
Other	4	18	19
Unallocated | Research and development
Segment reporting information
Stock-based compensation expense	347	296	226
Other	1	(14)	0
Unallocated | Selling, general, and administrative
Segment reporting information
Stock-based compensation expense	219	213	137
Unallocated | Other operating (income) expense, net
Segment reporting information
Patent license charges	57	0	0
Litigation settlement	0	0	68
Patent cross-license agreement gain	0	(200)	0
Other	$ 0	$ 5	$ 3